Discover the 2026 Product Catalog – The Latest in Autoimmune Diagnostics Medipan GmbH and GA Generic Assays GmbH proudly present the 2026 Product Catalog, showcasing our expanded portfolio of diagnostic solutions for autoimmune diseases. This edition highlights the latest innovations in immunodiagnostics and equips healthcare professionals, researchers, and laboratory partners with tools to advance diagnostics […]

Inflammatory bowel diseases (IBD), which include Crohn’s disease (CD) and ulcerative colitis (UC), are chronic disorders driven by immune dysregulation, environmental triggers, genetic predisposition, and alterations in the gut microbiota. Growing evidence highlights the role of serological biomarkers in IBD in improving disease characterization, early diagnostic refinement, and patient stratification. A new large-scale prospective investigation […]

Understanding Anti-GAD65 Antibodies and Their Clinical Significance Anti-glutamic acid decarboxylase antibodies (anti-GAD65) are among the most important biomarkers in autoimmune diseases. They play a dual diagnostic role: These antibodies can reach concentrations 100–500 times higher in neurological disease compared with diabetes, making quantitative accuracy crucial. A recently published scientific study evaluated the clinical performance of […]

November 17 – 20, 2025 | Messe Düsseldorf | Düsseldorf, Germany Medipan & GA Generic Assays at MEDICA 2025 This year, Medipan & GA Generic Assays will be participating in Hall 3 – Diagnostics Booth #3G60, where we will proudly showcase our latest products, technologies, and solutions. Visitors to our booth will have the opportunity […]

A German Pilot Study Using AI-Assisted Interpretation of ANA Artificial intelligence is rapidly transforming medical diagnostics—from radiology to immunology. Now, a new German pilot study reveals how AI-assisted interpretation of ANA tests could lead to faster, more consistent, and more reliable diagnosis of autoimmune diseases. With this study, the University Medical Center Regensburg and Asklepios […]

The Dresden Symposium on Autoantibodies reaffirmed its role as a landmark event, bringing together world-renowned experts to discuss the latest advances in autoimmunity. The symposium provided an invaluable opportunity to explore new perspectives on autoimmune diseases, emerging biomarkers, and technological innovations that are shaping the future of diagnostics and patient care. Medipan & GA Generic […]

Anti-neutrophil cytoplasmic antibodies (ANCA) Anti-neutrophil cytoplasmic antibodies (ANCA) are key biomarkers in the diagnosis of ANCA-associated vasculitis (AAV), a group of rare but potentially life-threatening autoimmune diseases. They can also have clinical and diagnostic value in certain non-AAV conditions. Early and accurate detection of ANCA is critical for initiating treatment promptly and improving long-term outcomes. […]

09 – 12, September 2025 | Dresden Fair | Dresden, Germany Medipan & GA at DSA 2025 – Leading Autoantibody Diagnostics Introduction to DSA 2025 We are pleased to announce that Medipan & GA Generic Assays will once again take part in the 17th Dresden Symposium on Autoantibodies (DSA) 2025. The symposium is one of […]

We are pleased to share the results of a newly published peer-reviewed study in Scientific Reports that demonstrates the diagnostic performance of the CytoBead® ANA 2 assay1. In clinical diagnostics, the detection of antinuclear antibodies (ANA) is crucial in identifying systemic autoimmune rheumatic diseases (SARDs). Traditional diagnostics use a two-step process. First, ANA screening by […]

Type 1 diabetes management has long relied on insulin injections, carbohydrate counting, and vigilant blood sugar monitoring. But how will the landscape in the near future look like? According to prominent German pediatric endocrinologist Felix Reschke (Kinder- und Jugendkrankenhaus in Hannover), the next five years could redefine treatment strategies entirely – he said in an […]